TW202539627A - 阿茲海默症預防或治療用組成物 - Google Patents

阿茲海默症預防或治療用組成物

Info

Publication number
TW202539627A
TW202539627A TW114101315A TW114101315A TW202539627A TW 202539627 A TW202539627 A TW 202539627A TW 114101315 A TW114101315 A TW 114101315A TW 114101315 A TW114101315 A TW 114101315A TW 202539627 A TW202539627 A TW 202539627A
Authority
TW
Taiwan
Prior art keywords
pls
composition
group
bace1
treatment
Prior art date
Application number
TW114101315A
Other languages
English (en)
Chinese (zh)
Inventor
藤野裕道
福島圭穰
岡林春花
琴浦聰
湯淺浩氣
Original Assignee
日商丸大食品股份有限公司
國立大學法人德島大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商丸大食品股份有限公司, 國立大學法人德島大學 filed Critical 日商丸大食品股份有限公司
Publication of TW202539627A publication Critical patent/TW202539627A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW114101315A 2024-01-15 2025-01-13 阿茲海默症預防或治療用組成物 TW202539627A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2024-003975 2024-01-15
JP2024003975 2024-01-15

Publications (1)

Publication Number Publication Date
TW202539627A true TW202539627A (zh) 2025-10-16

Family

ID=96471267

Family Applications (1)

Application Number Title Priority Date Filing Date
TW114101315A TW202539627A (zh) 2024-01-15 2025-01-13 阿茲海默症預防或治療用組成物

Country Status (3)

Country Link
JP (1) JP7765027B1 (https=)
TW (1) TW202539627A (https=)
WO (1) WO2025154692A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101787618B1 (ko) * 2010-09-24 2017-10-18 후지노 브레인 리서치 가부시키가이샤 항중추신경계 염증제

Also Published As

Publication number Publication date
JP7765027B1 (ja) 2025-11-06
JPWO2025154692A1 (https=) 2025-07-24
WO2025154692A1 (ja) 2025-07-24

Similar Documents

Publication Publication Date Title
JP3548102B2 (ja) 高血圧症予防・治療剤
JP6016363B2 (ja) 脳神経細胞新生剤
CN103118685A (zh) 抗中枢神经系统炎症的药物
JP6873504B2 (ja) アルツハイマー病の治療及び/又は予防のための組成物
AU2004238122B2 (en) Composition for lowering lipid in body
JP2004026803A (ja) 神経細胞死予防剤
TW202539627A (zh) 阿茲海默症預防或治療用組成物
JPH1084880A (ja) 脂質代謝促進作用を有するリン脂質含有組成物
EP1090635A2 (en) Use of ferulic acid for treating hypertension
KR101584431B1 (ko) 달맞이꽃 추출물을 유효성분으로 함유하는 미소중력하 또는 신경손상으로 인한 근위축 예방 또는 치료용 약학 조성물
JP2009510053A (ja) 桂皮抽出物を有効成分として含む腸内菌叢改善及び免疫機能増進用組成物
JP2010222284A (ja) 血中gip上昇抑制剤
JP7103748B2 (ja) Pcsk9阻害剤及びコレステロール代謝改善用食品組成物
KR102446154B1 (ko) Stat3 억제제를 유효성분으로 포함하는 면역질환 또는 염증성질환 예방 또는 치료용 약학적 조성물
JP6917040B2 (ja) 破骨細胞の形成または活性化抑制剤
JP2004137287A (ja) 高血圧症予防・治療剤
JP6045369B2 (ja) 一酸化窒素産生抑制剤
KR101359759B1 (ko) 펜톡시필린을 유효성분으로 함유하는 타우 단백질 과인산화 억제제
JP2018058792A (ja) Pcsk9阻害剤及びコレステロール代謝改善用食品組成物
US9526717B2 (en) Composition for treating immune diseases containing daurinol compound as active ingredient
JP6398014B2 (ja) ラマリンを含有する退行性脳疾患の予防または治療用組成物
JP2004131407A (ja) ローヤルゼリー又はその水溶性画分を有効成分とする抗うつ性組成物
JP2015067560A (ja) ラクトフェリンを含有する癌転移抑制剤
JP6153114B2 (ja) 扁平上皮癌予防剤、及び扁平上皮癌モデル動物及びその作製方法
JP2012019698A (ja) コラーゲンゲル収縮促進剤の選択方法